eli lilly and company news

Ro, Lilly and Zepbound

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline access to the popular treatment.

Business Insider · 12h

Ro, Eli Lilly to streamline patient access to Zepbound single-dose vials

Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients

Reuters · 13h

Telehealth firm Ro to provide single-dose vials of Lilly's Zepbound to obesity patients

Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity.

AOL · 12h

Ro partners with Eli Lilly to expand access to Zepbound vials

Eli Lilly has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound. Ro Health is joining other telehealth platforms an

10hon MSN

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro in a Swipe at Legal Copycats

Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the ...

Senior Housing News2h

Eli Lilly Partners with the Global Alzheimer’s Platform Foundation on Blood Test Study

Global Alzheimer's Platform Foundation (GAP) has partnered with Eli Lilly and Company (NYSE: LLY) for a study comparing blood ...

24/7 Wall St9h

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 504.34% and ...

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.

6don MSN

Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

17hon MSN

Will Eli Lilly's blockbuster obesity drug be available in India in 2025?

Tirzepatide had received approval in a single-dose prefilled pen format in January 2024 for use as an adjunct to diet and ...

Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump

Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug ...

STAT12h

Eli Lilly’s new maneuvers in GLP-1 treatment

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...

7don MSN

Eli Lilly Just Got a Bundle of Good News: Time to Buy?

One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company ...

Ibj.com1d

Lilly to test obesity drugs for addiction treatment, CEO says

The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Ro, Lilly and Zepbound

Related topics